Editorial

Dear Readers,
We have been undergoing turbulences in the last 2 years. There are many developments despite those challenges from COVID. Even though there is a gap between the last and this eNews Letter, we have come up with many new information. In the news section we are proudly announcing that the Sanat Product Limited, which was acquired recently, is now officially merged with Schwabe India. We have also covered the Schwabe India’s CSR initiative of distributing vendor cart to make daily wager independent along with other initiatives like MoU with RKG Group, SSAB meeting, etc.
Learning more about rare drugs is always fascinating and interesting. Alnus serrulata, Staphylococcinum, Galphimia glauca, and Amoora rohituka (Andersonia) are covered in the materia medica section. In the mother tinctures section, Ambrosia artemisiaefolia, Citrus limonum, Clerodendron infortunatum and Trichosanthes dioica are covered. Ambrosia artemisiaefolia is very effective remedy for the inflammation of mucous membrane. Citrus limonum is useful as anti-anemic, antimicrobial, anti-rheumatic, anti-sclerotic, antiseptic, bactericidal, carminative, cicatrisant, depurative, etc. Clerodendron infortunatum is chiefly used in gastric intestinal trouble. Trichosanthes dioica is used in malaria, kala-zar, nausea and vomiting.
Uses, efficacy and indications of Tussikind, Alpha-coff, Calciokind and Alpha-DP are discussed under product watch.
Animal study of our recently lunched product for joint pain has been discussed under research news. Apart from that efficacy of homoeopathy in HIV, post caesarean back pain and tonsillitis presented in research news.
Hope this issue would be informative.

Dr. R. Valavan
BHMS, MD (Hom), MBA
Editor

Editor